As gene and cell therapies mature, developers are increasingly looking beyond existing delivery systems to address challenges around targeting, immunogenicity, manufacturability, and cost. Dr. Angelo ...
ReiThera’s gorilla-derived adenovirus platform combines innate tumor selectivity, low seroprevalence, and systemic-delivery advantages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results